KBIO COMPANY Statistics

Total Valuation

KBIO COMPANY has a market cap or net worth of KRW 31.07 billion. The enterprise value is 30.10 billion.

Market Cap	31.07B
Enterprise Value	30.10B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 13.03% in one year.

Current Share Class	n/a
Shares Outstanding	115.50M
Shares Change (YoY)	+13.03%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.41
PB Ratio	0.29
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.43
EV / Sales	0.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-158.12

Financial Position

The company has a current ratio of 7.35, with a Debt / Equity ratio of 0.01.

Current Ratio	7.35
Quick Ratio	6.28
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-3.97
Interest Coverage	-14.23

Financial Efficiency

Return on equity (ROE) is -8.49% and return on invested capital (ROIC) is -0.58%.

Return on Equity (ROE)	-8.49%
Return on Assets (ROA)	-0.53%
Return on Invested Capital (ROIC)	-0.58%
Return on Capital Employed (ROCE)	-1.03%
Revenue Per Employee	2.32B
Profits Per Employee	-205.80M
Employee Count	33
Asset Turnover	0.59
Inventory Turnover	15.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.12% in the last 52 weeks. The beta is 0.79, so KBIO COMPANY's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+1.12%
50-Day Moving Average	247.06
200-Day Moving Average	260.43
Relative Strength Index (RSI)	58.93
Average Volume (20 Days)	1,988,022

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KBIO COMPANY had revenue of KRW 76.51 billion and -6.79 billion in losses. Loss per share was -59.00.

Revenue	76.51B
Gross Profit	11.66B
Operating Income	-1.11B
Pretax Income	-9.86B
Net Income	-6.79B
EBITDA	-25.92M
EBIT	-1.11B
Loss Per Share	-59.00

Full Income Statement

Balance Sheet

The company has 52.48 billion in cash and 754.97 million in debt, giving a net cash position of 51.73 billion or 447.86 per share.

Cash & Cash Equivalents	52.48B
Total Debt	754.97M
Net Cash	51.73B
Net Cash Per Share	447.86
Equity (Book Value)	107.08B
Book Value Per Share	487.71
Working Capital	61.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -119.17 million and capital expenditures -71.16 million, giving a free cash flow of -190.34 million.

Operating Cash Flow	-119.17M
Capital Expenditures	-71.16M
Free Cash Flow	-190.34M
FCF Per Share	-1.65

Full Cash Flow Statement

Margins

Gross margin is 15.24%, with operating and profit margins of -1.45% and -8.88%.

Gross Margin	15.24%
Operating Margin	-1.45%
Pretax Margin	-12.89%
Profit Margin	-8.88%
EBITDA Margin	-0.03%
EBIT Margin	-1.45%
FCF Margin	n/a

Dividends & Yields

KBIO COMPANY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.03%
Shareholder Yield	-13.03%
Earnings Yield	-21.86%
FCF Yield	-0.61%

Stock Splits

The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 27, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

KBIO COMPANY has an Altman Z-Score of 2.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.49
Piotroski F-Score	n/a